Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Anti-CD37 CAR T cells |
Trade Name | |
Synonyms | CAR-37 T cells|Anti-CD37-CAR-expressing T-lymphocytes |
Drug Descriptions |
Anti-CD37 CAR T cells consist of T-lymphocytes engineered to express a chimeric antigen receptor (CAR) that targets CD37 and contains a CD8 transmembrane domain linked to CD137 (4-1BB) and CD3 zeta signaling domains, which potentially induces cytotoxicty against tumor cells expressing CD37, and reduces tumor burden (PMID: 30089630). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C171034 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Anti-CD37 CAR T cells | Anti-CD37 CAR T cells | 0 | 1 |